NRD
OFIX icon

Nebula Research & Development’s Orthofix Medical OFIX Stock Holding History

Nebula Research & Development’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,384
Closed -$193K – 1050
2024
Q3 		$193K Sell
12,384
-6,735
-35% -$108K 0.02% 830
2024
Q2 		$254K Buy
19,119
+640
+3% +$8.77K 0.04% 656
2024
Q1 		$268K Sell
18,479
-287
-2% -$3.97K 0.06% 570
2023
Q4 		$253K Buy
18,766
+4,294
+30% +$50.5K 0.08% 483
2023
Q3 		$186K Buy
+14,472
New +$260K 0.1% 409

Other funds holding OFIX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $428M AUM 136.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nebula Research & Development's OFIX Position: Q4 2024 in Review

Nebula Research & Development sold out of Orthofix Medical (OFIX) in Q4 2024, closing a stake of 12,384 shares — an estimated $193K sold.

Nebula Research & Development first reported a position in OFIX in Q3 2023 and held it in 5 quarters. The position peaked at $268K in Q1 2024. 149 funds tracked by Wall St. Rank hold OFIX as of Q4 2024.

  • Nebula Research & Development reported no remaining Orthofix Medical position as of Q4 2024 after selling out during the quarter.
  • Nebula Research & Development sold 12,384 Orthofix Medical shares in Q4 2024, an estimated $193K.
  • Nebula Research & Development first reported a position in Orthofix Medical in Q3 2023 and held it in 5 quarters.
  • Nebula Research & Development's Orthofix Medical position peaked at $268K in Q1 2024.
  • 149 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2024.

Based on Nebula Research & Development's 13F filing for Q4 2024, filed 14 Feb 2025.